D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 42,939 305 World Ranking 7495 National Ranking 4044

Overview

What is he best known for?

The fields of study Jeffrey R. Marks is best known for:

  • Gene
  • Cancer
  • Enzyme

Internal medicine is intertwined with Oncology and Endocrinology in his research. Jeffrey R. Marks integrates Oncology with Cancer research in his study. Jeffrey R. Marks conducts interdisciplinary study in the fields of Cancer research and Tumor suppressor gene through his works. Jeffrey R. Marks undertakes multidisciplinary studies into Endocrinology and Internal medicine in his work. In his study, Jeffrey R. Marks carries out multidisciplinary Gene and Phosphorylation research. He integrates Phosphorylation with Gene in his research. Jeffrey R. Marks brings together Cancer and Angiogenesis to produce work in his papers. Jeffrey R. Marks merges many fields, such as Angiogenesis and Carcinogenesis, in his writings. Jeffrey R. Marks integrates Carcinogenesis with Tumor suppressor gene in his research.

His most cited work include:

  • Comprehensive molecular portraits of human breast tumours (8876 citations)
  • Oncogenic pathway signatures in human cancers as a guide to targeted therapies (1767 citations)
  • Predicting the clinical status of human breast cancer by using gene expression profiles (1244 citations)

What are the main themes of his work throughout his whole career to date

His Cancer study combines Breast cancer, Ovarian cancer and Carcinogenesis studies. In his works, he conducts interdisciplinary research on Breast cancer and Cancer research. Jeffrey R. Marks performs integrative study on Cancer research and Carcinogenesis. He merges many fields, such as Ovarian cancer and Cancer, in his writings. His Internal medicine study frequently draws connections between adjacent fields such as Serous fluid. His Genetics study frequently links to related topics such as Gene expression. Borrowing concepts from Pathology, Jeffrey R. Marks weaves in ideas under Oncology. He performs multidisciplinary studies into Pathology and Oncology in his work. He performs multidisciplinary studies into Biochemistry and Gene in his work.

Jeffrey R. Marks most often published in these fields:

  • Cancer (82.91%)
  • Internal medicine (63.25%)
  • Gene (62.39%)

What were the highlights of his more recent work (between 2018-2022)?

  • Cancer (70.00%)
  • Cancer research (60.00%)
  • Breast cancer (60.00%)

In recent works Jeffrey R. Marks was focusing on the following fields of study:

In his study, In situ is inextricably linked to Meteorology, which falls within the broad field of Infiltration (HVAC). Borrowing concepts from Meteorology, he weaves in ideas under In situ. His research investigates the link between Kurtosis and topics such as Statistics that cross with problems in Confidence interval. He combines Confidence interval and Statistics in his research. He integrates many fields, such as Cancer and Pathology, in his works. He integrates Pathology and Cancer in his research. He combines Cancer research and Colorectal cancer in his research. He conducts interdisciplinary study in the fields of Colorectal cancer and Somatic evolution in cancer through his research. In his works, Jeffrey R. Marks undertakes multidisciplinary study on Somatic evolution in cancer and Cancer research.

Between 2018 and 2022, his most popular works were:

  • Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression (208 citations)
  • Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set (102 citations)
  • Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma (87 citations)

In his most recent research, the most cited works focused on:

  • Cancer
  • Multivariate analysis
  • Multivariate statistics

With his scientific publications, his incorporates both Cancer research and Cancer. Jeffrey R. Marks conducts interdisciplinary study in the fields of Cancer and Magnetic resonance imaging through his research. His work blends Magnetic resonance imaging and Radiology studies together. Jeffrey R. Marks undertakes interdisciplinary study in the fields of Radiology and Oncology through his research. Jeffrey R. Marks performs integrative Oncology and Internal medicine research in his work. His Internal medicine study frequently intersects with other fields, such as Neoadjuvant therapy. His Neoadjuvant therapy study often links to related topics such as Breast cancer. Jeffrey R. Marks performs multidisciplinary study in the fields of Breast cancer and Cancer research via his papers. With his scientific publications, his incorporates both Cell biology and Biochemistry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt.
Nature (2012)

8574 Citations

Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

Andrea H. Bild;Guang Yao;Jeffrey T. Chang;Quanli Wang.
Nature (2006)

2256 Citations

Predicting the clinical status of human breast cancer by using gene expression profiles.

Mike West;Carrie Blanchette;Holly Dressman;Erich Huang.
Proceedings of the National Academy of Sciences of the United States of America (2001)

1697 Citations

BRCA1 mutations in primary breast and ovarian carcinomas

P. Andrew Futreal;Qingyun Liu;Donna Shattuck-Eidens;Charles Cochran.
Science (1994)

1682 Citations

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

Giovanni Ciriello;Giovanni Ciriello;Michael L. Gatza;Michael L. Gatza;Andrew H. Beck;Matthew D. Wilkerson.
Cell (2015)

1427 Citations

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Cell (2018)

1341 Citations

Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
(2020)

1275 Citations

Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression

Carey K. Anders;David S. Hsu;Gloria Broadwater;Chaitanya R. Acharya.
Journal of Clinical Oncology (2008)

945 Citations

Genomic signatures to guide the use of chemotherapeutics.

Anil Potti;Holly K Dressman;Andrea Bild;Richard F Riedel.
Nature Medicine (2006)

652 Citations

Compromised HOXA5 function can limit p53 expression in human breast tumours

Venu Raman;Shelby A. Martensen;David Reisman;Ella Evron.
Nature (2000)

627 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jeffrey R. Marks

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 147

Charles M. Perou

Charles M. Perou

University of North Carolina at Chapel Hill

Publications: 135

Andrew Berchuck

Andrew Berchuck

Duke University

Publications: 115

Jorge S. Reis-Filho

Jorge S. Reis-Filho

Memorial Sloan Kettering Cancer Center

Publications: 113

Vessela N. Kristensen

Vessela N. Kristensen

Oslo University Hospital

Publications: 103

Anne Lise Børresen-Dale

Anne Lise Børresen-Dale

Oslo University Hospital

Publications: 94

Joellen M. Schildkraut

Joellen M. Schildkraut

Emory University

Publications: 89

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 84

Christos Sotiriou

Christos Sotiriou

Université Libre de Bruxelles

Publications: 81

Carlos Caldas

Carlos Caldas

University of Cambridge

Publications: 80

Emad A. Rakha

Emad A. Rakha

University of Nottingham

Publications: 79

Sunil R. Lakhani

Sunil R. Lakhani

University of Queensland

Publications: 79

Kornelia Polyak

Kornelia Polyak

Harvard University

Publications: 78

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 76

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 75

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 71

Trending Scientists

Claudio Melchiorri

Claudio Melchiorri

University of Bologna

Alan Fern

Alan Fern

Oregon State University

Benjamin M. Friedman

Benjamin M. Friedman

Harvard University

Glenn S. Smith

Glenn S. Smith

Georgia Institute of Technology

Michael A. Henderson

Michael A. Henderson

Peter MacCallum Cancer Centre

Guifu Zou

Guifu Zou

Soochow University

Hans-Werner Mewes

Hans-Werner Mewes

Technical University of Munich

Kevin R. Pond

Kevin R. Pond

Texas Tech University

Josep Rizo

Josep Rizo

The University of Texas Southwestern Medical Center

James L. Davis

James L. Davis

Lamont-Doherty Earth Observatory

Amit Gross

Amit Gross

Ben-Gurion University of the Negev

Peter Rappelsberger

Peter Rappelsberger

University of Vienna

Gerhardt Attard

Gerhardt Attard

University College London

Kristina Sundquist

Kristina Sundquist

Lund University

Marilyn M. Wagener

Marilyn M. Wagener

University of Pittsburgh

Cathy D. Schleck

Cathy D. Schleck

Mayo Clinic

Something went wrong. Please try again later.